Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/24041
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSreekumar, E-
dc.contributor.authorDas, S K-
dc.date.accessioned2013-11-22T08:32:59Z-
dc.date.available2013-11-22T08:32:59Z-
dc.date.issued2001-10-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/24041-
dc.description989-992en_US
dc.description.abstractExperiments were conducted in chickens to understand the effects of oral immunomodulation. Heat inactivated M phlei, a commensal Mycobacterium and a non-specific immunomodulator, was administered orally prior to live Newcastle disease F (ND F) strain vaccination. In experimental birds it lead to an enhanced cell mediated Immune response (CMI) against the vaccine. There was a reduction in the Haemagglutination inhibiting (HI) antibodies. However, it did not affect the protection against a virulent challenge, as the protection percentage was more or less same in vaccinated birds irrespective of the M.phlei administration. M.phlei administration could not enhance the immune response to inactivated ND F vaccine administered orally. The results indicate that M.phlei favours a CMI response to orally administered live ND F vaccine. It may be of potential use in enhancing CMI against vaccines and a cheaper alternative to costlier recombinant cytokines. en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.39(10) [October 2001]en_US
dc.titleMycobacterium phlei as an oral immunomodulator with Newcastle disease vaccine en_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.39(10) [October 2001]

Files in This Item:
File Description SizeFormat 
IJEB 39(10) 989-992.pdf1.02 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.